PTGX financials

Protagonist Therapeutics (PTGX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

PTGX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$46.02M–-$158.13M-$130.15M-2.05
2024$434.43M–$252.84M$275.19M4.23
2023$60.00M–-$93.65M-$78.95M-1.39
2022$26.58M–-$131.37M-$127.39M-2.60
2021$27.36M–-$125.84M-$125.55M-2.71
2020$28.63M–-$64.52M-$66.15M-1.92